
Squawk on the Street Pullback After the Tech Rebound, More 737 MAX-9 Pressure On Boeing, CEOs Weigh In On Obesity Drugs 01/09/24
Jan 9, 2024
Guests on the podcast include Carl Quintanilla, Jim Cramer, and David Faber. They discuss stocks under pressure after the Nasdaq's rebound, new developments surrounding Boeing's grounded 737 MAX-9 jets, pharma CEOs' insights on the obesity drug market, Netflix downgrade, Samsung's profit miss impact, HPE's talks to acquire Juniper Networks, and Match Group's date with activism.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9
Introduction
00:00 • 2min
NVIDIA's Potential in Cloud Infrastructure
02:06 • 10min
The Importance of a Crew in the Front and Investment Opportunities
12:18 • 3min
Competition in the Weight Loss Drug Market
15:19 • 5min
Discussion on Jim's Second Day at the Conference and Netflix Downgrade
20:18 • 2min
Comparison between Netflix and Disney, the search for the number two player in the industry
21:59 • 2min
M&A Landscape and Stock Movement
23:50 • 15min
Uncertainty and Potential in the Market
38:38 • 3min
Discussions on Advertisers Paying to Reach Consumers in Europe
41:49 • 4min


